Novum Pharmaceutical Research Services
Houston, Texas, 77042-4712, United States
NCT Number: NCT00864240
To determine the dose-response relationship for Clobex TM (clobetasol propionate) Lotion, 0.05%. This information will be used to estimate the ED50, D1, D2 parameters for use in a full bioequivalence study.
Looking for future studies?
Notify Me18 year–50 year
Female
Interventional
Phase 1
Houston, Texas, 77042-4712, United States
Study Type: Interventional Study Design: Randomized, open label, one period, dose response, vasoconstrictor assay study.
Official Title: Dose Response of Clobex 0.05% Lotion
Further study details as provided by Actavis Elizabeth LLC:
Primary Outcome Measures:
· Vasoconstrictor Response
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects received Galderma Laboratories, L.P. formulated products
Other names: Clobetasol
Time frame: 24 hours
Actavis Inc.
Industry
Dose Response of Clobex 0.05% Lotion
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details